INTERNATIONAL PATENT: HIBERCELL, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER USING COMBINATIONS OF GCN2 MODULATORS AND BELZUTIFAN"

GENEVA, July 3 -- HIBERCELL, INC. (619 West 54th Street, 8th FloorNew York, New York 10016) filed a patent application (PCT/US2024/061769) for "METHODS OF TREATING CANCER USING COMBINATIONS OF GCN2 MODULATORS AND BELZUTIFAN" on Dec 23, 2024. With publication no. WO/2025/137710, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOSE, Nandita (c/o HiberCell, Inc.619 West 54th Street, 8th FloorNew York, New York 10016), GARGANO, Michele (c/o HiberCell, Inc.619 West 54th Street, 8th FloorNew York, New York 10016), IGLESIAS, Jos...